Skip to main content

Allergies and Cancers

  • Chapter
  • First Online:
Cancer Immunology
  • 1983 Accesses

Abstract

Worldwide, allergies and cancers cause significant amount of morbidity and mortality. An inverse association between allergies and cancers has been suggested; however, despite extensive research, the relationship remains elusive. On one side, allergies are accompanied by inflammatory reactions which constitute an optimal environment for carcinogenesis; thus promoting the development of tumors at this specific site. On the other side, systemic effects in terms of enhanced immuno-surveillance can likewise be evoked, thus preventing from cancer at other areas. This chapter presents an overview about studies investigating the relationship between allergies and cancers. In addition, it describes possible mechanisms, which could explain them.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012 – Torre – 2015 – CA: a Cancer Journal for Clinicians – Wiley Online Library CA. Cancer J Clin. 2015;65:87–108.

    Article  Google Scholar 

  2. Robert Koch-Institut. Gesundheit in Deutschland. Berlin: Gesundheitsberichterstattung des Bundes; 2015.

    Google Scholar 

  3. American Cancer Society. Cancer facts & figures 2017. Atlanta: American Cancer Society; 2017.

    Google Scholar 

  4. Langen U, Schmitz R, Steppuhn H. Häufigkeit allergischer Erkrankungen in Deutschland. Bundesgesundheitsblatt. 2013;56:698–706.

    Article  CAS  Google Scholar 

  5. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 2004;59:469–78.

    Article  PubMed  Google Scholar 

  6. Jensen-Jarolim E, Turner MC, Karagiannis S. Allergo Oncology: IgE- and IgG4-mediated immune mechanisms linking allergy with cancer and their translational implications. J Allergy Clin Immunol. 2017;140:982–4.

    Article  PubMed  Google Scholar 

  7. Carrozzi L, Viegi G. Allergy and cancer: a biological and epidemiological rebus. Allergy. 2005;60:1095–7.

    Article  CAS  PubMed  Google Scholar 

  8. Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology. 2005;128:1089–113.

    Article  CAS  PubMed  Google Scholar 

  9. Grammatikos AP. The genetic and environmental basis of atopic diseases. Ann Med. 2008;40:482–95.

    Article  CAS  PubMed  Google Scholar 

  10. Newman Taylor AJ. ABC of allergies. Asthma and allergy. Br Med J. 1998;316:997–9.

    Article  Google Scholar 

  11. Strachan DP. Hay fever, hygiene, and household size. Br Med J. 1989;299:1259–60.

    Article  CAS  Google Scholar 

  12. Shakib F, Ghaemmaghami AM, Sewell HF. The molecular basis of allergenicity. Trends Immunol. 2008;29:633–42.

    Article  CAS  PubMed  Google Scholar 

  13. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol. 2000;105:399–408.

    Article  CAS  PubMed  Google Scholar 

  14. Robinson DS. The Th1 and Th2 concept in atopic allergic disease. Chem Immunol. 2000;78:50–61.

    Article  CAS  PubMed  Google Scholar 

  15. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol. 2003;3:721–32.

    Article  CAS  PubMed  Google Scholar 

  16. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol. 2008;8:205–17.

    Article  CAS  PubMed  Google Scholar 

  17. Gauchat J, Henchoz S, Mazzei G, Aubry J, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Bonnefoy J. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature. 1993;365:340–3.

    Article  CAS  PubMed  Google Scholar 

  18. Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol. 2006;18:751–60.

    Article  CAS  PubMed  Google Scholar 

  19. González-Pérez A, Fernández-Vidaurre C, Rueda A, Rivero E, García Rodríguez LA. Cancer incidence in a general population of asthma patients. Pharmaco Epidemiol Drug Saf. 2006;15:131–8.

    Article  Google Scholar 

  20. Kay AB. Overview of ‘allergy and allergic diseases: with a view to the future’. Br Med Bull. 2000;56:843–64.

    Article  CAS  PubMed  Google Scholar 

  21. Hagströmer L, Ye W, Nyrén O, Emtestam L. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol. 2005;141:1123–7.

    Article  PubMed  Google Scholar 

  22. Weinberg RA. The biology of cancer. New York: Garland Science; 2007.

    Google Scholar 

  23. Knudson AG. Cancer genetics. Am J Med Genet. 2002;111:96–102.

    Article  PubMed  Google Scholar 

  24. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316–23.

    Article  CAS  PubMed  Google Scholar 

  25. Jakóbisiak M, Lasek W, Golab J. Natural mechanisms protecting against cancer. Immunol Lett. 2003;90:103–22.

    Article  CAS  PubMed  Google Scholar 

  26. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.

    Article  CAS  PubMed  Google Scholar 

  27. Croce CM. Oncogenes and cancer. New Engl J Med. 2008;358:502–11.

    Article  CAS  PubMed  Google Scholar 

  28. Delaval B, Birnbaum D. A cell cycle hypothesis of cooperative oncogenesis (review). Int J Oncol. 2007;30:1051–8.

    CAS  PubMed  Google Scholar 

  29. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med. 2007;13:535–41.

    Article  CAS  PubMed  Google Scholar 

  31. Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. Krebs in Deutschland 2005/2006. Häufigkeiten und Trends. 2010.

    Google Scholar 

  32. Wiemels JL, Wrensch M, Sison JD, Zhou M, Bondy M, Calvocoressi L, Black PM, Yu H, Schildkraut JM, Claus EB. Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer. 2011;129:1932–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3:991–8.

    Article  CAS  PubMed  Google Scholar 

  34. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21:137–48.

    Article  CAS  PubMed  Google Scholar 

  35. Morse MA, Lyerly HK, Clay TM, Abdel-Wahab O, Chui SY, Garst J, Gollob J, Grossi PM, Kalady M, Mosca PJ, Onaitis M, Sampson JH, Seigler HF, Toloza EM, Tyler D, Vieweg J, Yang Y. How does the immune system attack cancer? Curr Probl Surg. 2004;41:15–132.

    Article  PubMed  Google Scholar 

  36. Ikeda H, Old LJ, Schreiber RD. The roles of IFNγ in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002;13:95–109.

    Article  CAS  PubMed  Google Scholar 

  37. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Anonymous. 2004;22:329–60.

    CAS  Google Scholar 

  38. Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL. The immune hallmarks of cancer. Cancer Immunol Immunother. 2011;60:319–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Fisherman EW. Does the allergic diathesis influence malignancy? J Allergy. 1960;31:74–8.

    Article  CAS  PubMed  Google Scholar 

  40. Martin EG. Predisposing factors and diagnosis of rectal cancer: a discussion of allergy. Ann Surg. 1935;102:56–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy. 2005;60:1098–11.

    Article  CAS  PubMed  Google Scholar 

  42. Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol. 2005;162:212–21.

    Article  PubMed  Google Scholar 

  43. McWhorter WP. Allergy and risk of cancer. A prospective study using NHANESI followup data. Cancer. 1988;62:451–5.

    Article  CAS  PubMed  Google Scholar 

  44. Mackay WD. The incidence of allergic disorders and cancer. Br J Cancer. 1966;20:434–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Allegra J, Lipton A, Harvey H, Luderer J, Brenner D, Mortel R, Demers L, Gillin M, White D, Trautlein J. Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res. 1976;36:3225–6.

    CAS  PubMed  Google Scholar 

  46. Vena JE, Bona JR, Byers TE. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol. 1985;122:66–74.

    Article  CAS  PubMed  Google Scholar 

  47. Mills PK, Beeson WL, Fraser GE, Phillips RL. Allergy and cancer: organ site-specific results from the Adventist health study. Am J Epidemiol. 1992;136:287–95.

    Article  CAS  PubMed  Google Scholar 

  48. Hwang CY, Chen YJ, Lin MW, Chen TJ, Chu SY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer. 2012;130(5):1160–7.

    Article  CAS  PubMed  Google Scholar 

  49. Vesterinen E, Pukkala E, Timonen T, Aromaa A. Cancer incidence among 78 000 asthmatic patients. Int J Epidemiol. 1993;22:976–82.

    Article  CAS  PubMed  Google Scholar 

  50. Olesen AB, Engholm G, Storm HH, Thestrup-Pedersen K. The risk of cancer among patients previously hospitalized for atopic dermatitis. J Invest Dermatol. 2005;125:445–9.

    Article  CAS  PubMed  Google Scholar 

  51. Arana A, Wentworth CE, Fernández-Vidaurre C, Schlienger RG, Conde E, Arellano FM. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol. 2010;163:1036–43.

    Article  CAS  PubMed  Google Scholar 

  52. Shapiro S, Heinonen OP, Siskind V. Cancer and allergy. Cancer. 1971;28:396–400.

    Article  CAS  PubMed  Google Scholar 

  53. Eriksson NE, Mikoczy Z, Hagmar L. Cancer incidence in 13811 patients skin tested for allergy. J Invest Allergol Clin Immunol. 2005;15:161–6.

    CAS  Google Scholar 

  54. Lindelöf B, Granath F, Tengvall-Linder M, Ekbom A. Allergy and cancer. Allergy. 2005;60:1116–20.

    Article  PubMed  Google Scholar 

  55. Pompei R, Lampis G, Ingianni A, Nonnis D, Ionta MT, Massidda B. Allergy and tumour outcome after primary cancer therapy. Int Arch Allergy Immunol. 2004;133:174–8.

    Article  PubMed  Google Scholar 

  56. Taghizadeh N, Vonk JM, Hospers JJ, Postma DS, de Vries EGE, Schouten JP, et al. Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort. Cancer Causes Control. 2015;26:99–109.

    Article  PubMed  Google Scholar 

  57. El-Zein M, Parent ME, Siemiatycki J, Rousseau MC. History of allergic diseases and lung cancer risk. Ann Allergy Asthma Immunol. 2014;112:230–6.

    Article  PubMed  Google Scholar 

  58. Wang H, Rothenbacher D, Löw M, Stegmaier C, Brenner H, Diepgen TL. Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer. 2006;119:695–701.

    Article  CAS  PubMed  Google Scholar 

  59. Turner MC, Chen Y, Krewski D, Ghadirian P. An overview of the association between allergy and cancer. Int J Cancer. 2006;118:3124–32.

    Article  CAS  PubMed  Google Scholar 

  60. Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control. 2003;14:327–34.

    Article  PubMed  Google Scholar 

  61. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.

    Article  CAS  PubMed  Google Scholar 

  62. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.

    Article  CAS  PubMed  Google Scholar 

  63. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. New Engl J Med. 1986;315:1650–9.

    Article  CAS  PubMed  Google Scholar 

  64. Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749–59.

    Article  CAS  PubMed  Google Scholar 

  65. Holly EA, Eberle CA, Bracci PM. Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol. 2003;158:432–41.

    Article  PubMed  Google Scholar 

  66. Eppel A, Cotterchio M, Gallinger S. Allergies are associated with reduced pancreas cancer risk: a population-based case-control study in Ontario, Canada. Int J Cancer. 2007;121:2241–5.

    Article  CAS  PubMed  Google Scholar 

  67. Cotterchio M, Lowcock E, Hudson TJ, Greenwood C, Gallinger S. Association between allergies and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2014;23:469–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Gomez-Rubio P, Zock J, Rava M, Marquez M, Sharp L, Hidalgo M, et al. Reduced risk of pancreatic cancer associated with asthma and nasal allergies. Gut. 2017;66:314–22.

    Article  PubMed  Google Scholar 

  69. Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC. Allergies, variants in IL-4 and IL-4Rα genes, and risk of pancreatic cancer. Cancer Detect Prev. 2007;31:345–51.

    Article  CAS  PubMed  Google Scholar 

  70. Olson SH, Chou JF, Ludwig E, O’Reilly E, Allen PJ, Jarnagin WR, Bayuga S, Simon J, Gonen M, Reisacher WR, Kurtz RC. Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer. 2010;127:2412–9.

    Article  CAS  PubMed  Google Scholar 

  71. Negri E, Bosetti C, La Vecchia C, Levi F, Tomei F, Franceschi S. Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer. 1999;35:1838–41.

    Article  CAS  PubMed  Google Scholar 

  72. Bosetti C, Talamini R, Franceschi S, Negri E, Giacosa A, La Vecchia C. Allergy and the risk of selected digestive and laryngeal neoplasms. Eur J Cancer Prev. 2004;13:173–6.

    Article  CAS  PubMed  Google Scholar 

  73. Tambe NA, Wilkens LR, Wan P, Stram DO, Gilliland F, Park SL, et al. Atopic allergic conditions and colorectal cancer risk in the Multiethnic Cohort Study. Am J Epidemiol. 2015;181:889–97.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Prizment AE, Folsom AR, Cerhan JR, Flood A, Ross JA, Anderson KE. History of allergy and reduced incidence of colorectal cancer, Iowa women’s health study. Cancer Epidemiol Biomarkers Prev. 2007;16:2357–62.

    Article  PubMed  Google Scholar 

  75. Jacobs EJ, Gapstur SM, Newton CC, Turner MC, Campbell PT. Hay fever and asthma as markers of atopic immune response and risk of colorectal cancer in three large cohort studies. Cancer Epidemiol Biomarkers Prev. 2013;22:661–9.

    Article  CAS  PubMed  Google Scholar 

  76. Ma W, Yang J, Li P, Lu X, Cai J. Association between allergic conditions and colorectal cancer risk/mortality: a meta-analysis of prospective studies. Sci Rep. 2017;7:5589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer. 2002;99:252–9.

    Article  CAS  PubMed  Google Scholar 

  78. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, Van Tongeren M, Muir KR. History of allergies and risk of glioma in adults. Int J Cancer. 2006;119:2165–72.

    Article  CAS  PubMed  Google Scholar 

  79. Wigertz A, Lönn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, Johansen C, Klæboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T, Feychting M. Allergic conditions and brain tumor risk. Am J Epidemiol. 2007;166:941–50.

    Article  PubMed  Google Scholar 

  80. Roncarolo F, Infante-Rivard C. Asthma and risk of brain cancer in children. Cancer Causes Control. 2012;23:617–23.

    Article  PubMed  Google Scholar 

  81. Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, Schwartzbaum J, Heimberger A, Sampson JH, Chang S, Prados M, Wiencke JK, Wrensch M. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer. 2009;125:680–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A, Feychting M, Grimsrud TK. Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst. 2012;104:1251–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Turner MC, Krewski D, Armstrong BK, Chetrit A, Giles GG, Hours M, McBride ML, Parent ME, Sadetzki S, Siemiatycki J, Woodward A, Cardis E. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control. 2013;24:949–60.

    Article  PubMed  Google Scholar 

  84. Amirian ES, Zhou R, Wrensch MR, Olson SH, Scheurer ME, Il’yasova D, et al. Approaching a scientific consensus on the association between allergies and glioma risk: a report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2016;25:282–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Krejsek J, Král B, Vokurková D, Derner V, Toušková M, Paráková Z, Kopecký O. Decreased peripheral blood γδ T-cells in patients with bronchial asthma. Allergy. 1998;53:73–7.

    Article  CAS  PubMed  Google Scholar 

  86. Mesdaghi M, Vodjgani M, Salehi E, Hadjati J, Sarrafnejad A, Bidad K, Berjisian F. Natural killer cells in allergic rhinitis patients and nonatopic controls. Int Arch Allergy Immunol. 2010;153:234–8.

    Article  CAS  PubMed  Google Scholar 

  87. Timonen T, Stenius-Aarniala B. Natural killer cell activity in asthma. Clin Exp Immunol. 1985;59:85–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet. 2000;356:1795–9.

    Article  CAS  PubMed  Google Scholar 

  89. Rothenberg ME. Eosinophilia. New Engl J Med. 1998;338:1592–600.

    Article  CAS  PubMed  Google Scholar 

  90. Rivoltini L, Viggiano V, Spinazze S, Santoro A, Colombo MP, Takatsu K, Parmiani G. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5. Int J Cancer. 1993;54:8–15.

    Article  CAS  PubMed  Google Scholar 

  91. Munitz A, Levi-Schaffer F. Eosinophils: ‘New’ roles for ‘old’ cells. Allergy. 2004;59:268–75.

    Article  CAS  PubMed  Google Scholar 

  92. Ellyard JI, Simson L, Parish CR. Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens. 2007;70:1–11.

    Article  CAS  PubMed  Google Scholar 

  93. Simson L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, Smyih MJ, Parish CR. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol. 2007;178:4222–9.

    Article  CAS  PubMed  Google Scholar 

  94. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol. 2000;105:651–63.

    Article  CAS  PubMed  Google Scholar 

  95. Pereira MC, Oliveira DT, Kowalski LP. The role of eosinophils and eosinophil cationic protein in oral cancer: a review. Arch Oral Biol. 2011;56:353–8.

    Article  CAS  PubMed  Google Scholar 

  96. Karagiannis SN, Bracher MG, Beavil RL, Beavil AJ, Hunt J, McCloskey N, Thompson RG, East N, Burke F, Sutton BJ, Dombrowicz D, Balkwill FR, Gould HJ. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother. 2008;57:247–63.

    Article  CAS  PubMed  Google Scholar 

  97. Gould HJ, Mackay GA, Karagiannis SN, O’Toole CM, Marsh PJ, Daniel BE, Coney LR, Zurawski VR Jr, Joseph M, Capron M, Gilbert M, Murphy GF, Korngold R. Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur J Immunol. 1999;29:3527–37.

    Article  CAS  PubMed  Google Scholar 

  98. Reali E, Greiner JW, Corti A, Gould HJ, Bottazzoli F, Paganelli G, Schlom J, Siccardi AG. IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines. Cancer Res. 2001;61:5517–22.

    CAS  PubMed  Google Scholar 

  99. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR, Parsa AT, Sison JD, Prados MD. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006;66:4531–41.

    Article  CAS  PubMed  Google Scholar 

  100. Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol. 2008;153:401–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Marone G, Varricchi G, Loffredo S, Granata F. Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis. Eur J Pharmacol. 2015;778:146–51.

    Article  CAS  PubMed  Google Scholar 

  102. Varricchi G, Galdiero MR, Loffredo S, Marone G, Iannone R, Marone G, et al. Are mast cells MASTers in cancer? Front Immunol. 2017;8:424.

    PubMed  PubMed Central  Google Scholar 

  103. Terabe M, Park JM, Berzofsky JA. Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother. 2004;53:79–85.

    Article  CAS  PubMed  Google Scholar 

  104. Mocellin S, Wang E, Marincola FM. Cytokines and immune response in the tumor microenvironment. J Immunother. 2001;24:392–407.

    Article  CAS  PubMed  Google Scholar 

  105. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science. 1992;257:548–51.

    Article  CAS  PubMed  Google Scholar 

  106. Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP. Inhibition of angiogenesis by interleukin 4. J Exp Med. 1998;188:1039–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Obiri NI, Siegel JP, Varricchio F, Puri RK. Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol. 1994;95:148–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Son DJ, Jung YY, Park MH, Lee HL, Song MJ, Yoo HS, et al. Activated natural killer cells mediate the suppressive effect of Interleukin-4 on tumor development via STAT6 activation in an atopic condition Melanoma Model. Neoplasia. 2017;19:537–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Tirado-Rodriguez B, Ortega E, Segura-Medina P, Huerta-Yepez S. TGF-beta: an important mediator of allergic disease and a molecule with dual activity in cancer development. J Immunol Res. 2014;2014:318481.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Pinto FCH, Menezes GB, Moura SAL, Cassali GD, Teixeira MM, Cara DC. Induction of apoptosis in tumor cells as a mechanism of tumor growth reduction in allergic mice. Pathol Res Pract. 2009;205:559–67.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Axel Lorentz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Waldenmaier, D., Lorentz, A. (2020). Allergies and Cancers. In: Rezaei, N. (eds) Cancer Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-30845-2_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-30845-2_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-30844-5

  • Online ISBN: 978-3-030-30845-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics